UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model
Objectives In 2002, the UK's National Institute for Health and Care Excellence concluded that the multiple sclerosis (MS) disease modifying therapies; interferon-β and glatiramer acetate, were not cost effective over the short term but recognised that reducing disability over the longer term mi...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2014-01-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/4/1/e004073.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|